Alzheimer's Disease
Showing NaN - NaN of 73
Alzheimer's Disease Trial in Worldwide (GSK4527226, Placebo)
Not yet recruiting
- Alzheimer's Disease
- GSK4527226
- Placebo
-
San Diego, California
- +99 more
Oct 6, 2023
Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Active, not recruiting
- Alzheimer's Disease
- Semorinemab
- +2 more
-
Garden Grove, California
- +48 more
Sep 1, 2022
Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)
Recruiting
- Alzheimer's Disease
- Placebo
- Bepranemab
-
Sun City, Arizona
- +115 more
Aug 18, 2022
Alzheimer's Disease Trial in Worldwide (Placebo, Gantenerumab)
Alzheimer's Disease Trial in United States (TB006, Placebo)
Active, not recruiting
- Alzheimer's Disease
- TB006
- Placebo
-
Garden Grove, California
- +17 more
May 29, 2022
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Agitation, Alzheimer's Disease Trial in United States (AVP-923-20, Placebo, AVP-923-30)
Cognitive Dysfunction, Alzheimer's Disease Trial in United States (Aducanumab, Placebo)
Terminated
- Cognitive Dysfunction
- Alzheimer's Disease
- Aducanumab
- Placebo
-
Phoenix, Arizona
- +21 more
Aug 19, 2021
Alzheimer's Disease Trial in San Diego, Cleveland (AAV2-BDNF Gene Therapy)
Recruiting
- Alzheimer's Disease
- AAV2-BDNF Gene Therapy
-
San Diego, California
- +1 more
Sep 1, 2021
Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (BIIB037)
- Placebo
-
Birmingham, Alabama
- +179 more
Aug 9, 2021
Alzheimer's Disease Trial in Worldwide (LY3202626, Placebo)
Alzheimer's Disease Trial in Worldwide (Elenbecestat, Placebo)
Alzheimer's Disease Trial in United States (CERE-110: Adeno-Associated Virus injection Surgery, Placebo Surgery)
Completed
- Alzheimer's Disease
- CERE-110: Adeno-Associated Virus injection Surgery
- Placebo Surgery
-
Birmingham, Alabama
- +9 more
Dec 14, 2020
Alzheimer's Disease Trial in Worldwide (PF-04447943, Placebo)
Alzheimer's Disease Trial in Australia, United States (Flortaucipir F18, PET Scan)
Completed
- Alzheimer's Disease
- Flortaucipir F18
- PET Scan
-
Phoenix, Arizona
- +30 more
Sep 3, 2020
Alzheimer's Disease Trial in United States (Aducanumab (recombinant, fully human anti-Aß IgG1 mAb), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb)
- Placebo
-
Tucson, Arizona
- +31 more
Jul 31, 2020
Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)
Terminated
- Alzheimer's Disease
- Behavioral Variant Frontotemporal Dementia
-
Phoenix, Arizona
- +134 more
May 15, 2020